Literature DB >> 34095794

Second wave of COVID-19 pandemic in India: Barriers to effective governmental response.

Sujita Kumar Kar1, Ramdas Ransing2, S M Yasir Arafat3, Vikas Menon4.   

Abstract

Entities:  

Year:  2021        PMID: 34095794      PMCID: PMC8164526          DOI: 10.1016/j.eclinm.2021.100915

Source DB:  PubMed          Journal:  EClinicalMedicine        ISSN: 2589-5370


× No keyword cloud information.
Like several parts of the world, especially Europe, India has been experiencing a massive surge of COVID-19 cases and deaths. As of April 10, 2021, India is the 3rd leading country based on the USA and Brazil's identified cases [1]. Since the middle of March 2021, the second wave has started, and on April 09, the highest number of cases (144,829) has been identified in India [1]. The major affected states are Maharashtra, Kerala, Karnataka, Andhra Pradesh, Tamil Nadu, Andhra Pradesh, Delhi, Uttar Pradesh, and West Bengal. Despite this high caseload, several national movements such as the farmers' movement, election in several states have been going on. Those can increase the risk of transmission of COVID-19. During the 1st wave, the central government imposed a nationwide lockdown on March 25, 2020. The result revealed a well-controlled infection rate and the Indian policy was appreciated internationally. Although several countries in Europe imposed lockdown in several formats, surprisingly, in the second wave, there appears to be a lack of coordination between different health agencies and the government in India. Below, we list a few speculative reasons for this: As per the constitution of India, health is a state subject, which means that the state government, and not central government, should be the one calling the shots. However, during the first wave of COVID-19 in India, the central government crossed constitutional boundaries and imposed lockdown on all states. At the same time, the state government has limitations in their human resources and technical expertise which affects their ability to scale up key public health interventions for COVID-19 such as the vaccination strategies. The Indian Council of Medical Research (ICMR), All India Institute of Medical Sciences (AIIMS), or other apex medical institutes of national importance, National Centre for Disease Control, and National Health System Resources Centre are the premier medical institutes of the central government. They have the services of public health experts but, thus far, in the second wave, their role has been confined to an advisory for public health of state. In other words, several administrative barriers are affecting the co-ordination among the state, centre and national institutes and may be a contributor to the inadequate response to COVID-19 during the second wave. India is a country with a huge population with regional variations in health literacy, health care inequity, and poor risk perceptions among the general people [2]. There is a challenge to vaccinate the whole population even though the country has the largest vaccine-producing units. Immediate national and international attention is needed to identify the appropriate containment strategy of the pandemic. Otherwise, the world may lose many lives that could be saved by political wills considering the general people's safety than winning in the immediate election. In India, March to June is the time, during which most of the school examinations and higher competitive examinations are conducted. Due to COVID-19 pandemic related academic loss and delay or postponement of the examinations many students committed suicide in India in 2020 [3]. In the year 2021, having a peak in this time imposes threat to students due to uncertainty as many examinations are delayed for indefinite periods. At the same time, paradoxically, it has been reported that mass gatherings in religious places, festivals that encourage mass participation, political rallies and even protests are going on in an uncontrolled manner. It clearly indicates that there is no or ineffective policy to streamline things to keep the upsurge of COVID-19 cases in control. It is high time to take drastic steps to contain the rapid growth of COVID-19 cases in resource exhausted country like India. In a pandemic like situation, we recommend a clear division of responsibilities between central and state governments and establishment of a nodal COVID management agency that will oversee nation-wide efforts to combat the COVID-19 crisis.

Declaration of Competing Interest

Sujita Kar, SMY Arafat and Vikas Menon declare that there is no conflict of interests. Ramdas Ransing has received research grant (outside the submitted work) from Indian Council of Medical Research for BIND-P (Perinatal depression) project (No. 5/4–4/151/M/2017/NCD-I). ICMR is a government owned not-for-profit organisation, and the apex regulator for medical research in India.
  1 in total

1.  Impending Second Wave of COVID-19 Infections: What India Needs to Do?

Authors:  Vikas Menon; Sujita Kumar Kar; Ramdas Ransing; S M Yasir Arafat
Journal:  Asia Pac J Public Health       Date:  2021-03-05       Impact factor: 1.399

  1 in total
  27 in total

1.  Hematological Changes in the Second Wave of SARS-CoV-2 in North India.

Authors:  Akanksha Singh; Shailendra P Verma; Rashmi Kushwaha; Wahid Ali; Himanshu D Reddy; Uma S Singh
Journal:  Cureus       Date:  2022-03-25

Review 2.  Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario.

Authors:  T K Suvvari; C P; S Kuppili; V Kandi; L V S Kutikuppala; V D K Kandula; S Mishra; A K Sarangi; R K Mohapatra; K Dhama
Journal:  Arch Razi Inst       Date:  2021-11-30

3.  The Impact of Neocolonialism on India's COVID-19 Response.

Authors:  Dhruv M Shah; Mrunmayi Kulkarni; Poonam Mathur
Journal:  Ann Glob Health       Date:  2022-05-17       Impact factor: 3.640

4.  Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India.

Authors:  Vijay Rani Rajpal; Shashi Sharma; Avinash Kumar; Samantha Vaishnavi; Apekshita Singh; Deepmala Sehgal; Mughdha Tiwari; Shailendra Goel; Soom Nath Raina
Journal:  Future Virol       Date:  2022-06-03       Impact factor: 3.015

5.  Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction.

Authors:  Priyanka Mehta; Varsha Ravi; Priti Devi; Ranjeet Maurya; Shaista Parveen; Pallavi Mishra; Aanchal Yadav; Aparna Swaminathan; Sheeba Saifi; Kriti Khare; Partha Chattopadhyay; Monika Yadav; Nar Singh Chauhan; Bansidhar Tarai; Sandeep Budhiraja; Uzma Shamim; Rajesh Pandey
Journal:  Microbiol Res       Date:  2022-06-25       Impact factor: 5.070

6.  Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India.

Authors:  Hirawati Deval; Dimpal A Nyayanit; Shailendra Kumar Mishra; Pragya D Yadav; Kamran Zaman; Prem Shankar; Brij R Misra; Sthita Pragnya Behera; Niraj Kumar; Abhinendra Kumar; Pooja Bhardwaj; Gaurav Raj Dwivedi; Rajeev Singh; Anita M Shete; Priyanka Pandit; Ashok K Pandey; Girijesh Kumar Yadav; Shashi Gupta; Manoj Kumar; Asif Kavathekar; Ravi Shankar Singh; Sanjay Prajapati; Rajni Kant
Journal:  Front Med (Lausanne)       Date:  2022-01-07

Review 7.  Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines.

Authors:  Hardeep Singh Tuli; Katrin Sak; Poonam Aggarwal; Ashif Iqubal; Sushil K Upadhaya; Jagjit Kaur; Ginpreet Kaur; Diwakar Aggarwal
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

8.  Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study.

Authors:  Manisha Ghate; Pallavi Shidhaye; Shraddha Gurav; Keshav Gadhe; Varsha Kale; Preeti Jain; Madhuri Thakar
Journal:  J Int Assoc Provid AIDS Care       Date:  2022 Jan-Dec

9.  The prioritation and gap of preoperative COVID-19 vaccination in cancer surgery of the breast, head and neck, and skin: A cohort study of 367 patients in an Indonesian hospital.

Authors:  Sumadi Lukman Anwar; Roby Cahyono; Herjuna Hardiyanto; Suwardjo Suwardjo; Darwito Darwito; Wirsma Arif Harahap
Journal:  Ann Med Surg (Lond)       Date:  2021-11-18

10.  Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019.

Authors:  Anshuman Elhence; Manas Vaishnav; Sagnik Biswas; Abhinav Anand; Deepak Gunjan; Saurabh Kedia; Soumya J Mahapatra; Baibaswata Nayak; Sabreena Sheikh; Kapil D Soni; Anjan Trikha; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.